104 results on '"C.A. Bravi"'
Search Results
2. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
3. The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials
4. Are men with low risk prostate cancer but high pirads score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
5. Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series
6. Age and Gleason score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the mp-MRI era?
7. The current role of renal tumour biopsy in the management of patients with suspected renal cancer: a prospective observational study
8. Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function
9. Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes?
10. Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy
11. Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data
12. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance. results from a single institution series
13. Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
14. A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
15. Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
16. Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H
17. Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient stratification for tailored post-operative treatments
18. A prospective, randomized, phase 3 trial assessing the impact of Early Dorsal Venous Complex (EDVC) ligation on urinary continence recovery after robot-assisted radical prostatectomy. results of an interim analysis on early post-operative outcomes
19. What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series
20. Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal approach
21. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database
22. The healthier the patient, the longer the ischemia: Surgical implications for partial nephrectomy in the RECORd2 project
23. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
24. When is mp-MRI reliable in predicting extra-prostatic extension in prostate cancer patients treated with radical prostatectomy? Results from a large, multi-institutional series
25. Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. The importance of patient stratification for tailored post-operative treatments
26. Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
27. Multiparametric MRI of the prostate significantly underestimates tumor volume of small visible lesions. Implications for tailored focal therapy approaches
28. A positive PSMA PET/CT predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
29. Analysis of CKD progression for purely Off-Clamp and On-Clamp robotic partial nephrectomy for high nephrometry renal masses: Results of a multicentric series
30. Impact of benign histology on perioperative complication and functional outcomes of robot assisted partial nephrectomy
31. Multicenter experience in minimally invasive adrenalectomy for the treatment of Adreno Cortical Carcinoma (ACC): A Junior ERUS/YAU robotic study
32. Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center
33. Survival after radical prostatectomy vs. radiation therapy in clinical node positive prostate cancer patients: A multicentric study
34. Real-life performance of imaging vs. nomograms for the assessment of lymph-node involvement in prostate cancer: Should we trust radiology?
35. When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification
36. Are we improving rates of pentafecta achievement after robot-assisted partial nephrectomy? A single high-volume institution experience over more than a decade
37. Reliability of 68Ga-PSMA PET/CT in assessing real nodal burden in men with cN1 disease: clinical implications for patient counselling and multi-modal treatments
38. The key role of concomitant androgen-deprivation therapy on the efficacy of imaging guided treatments in men with biochemical recurrent prostate cancer after radical prostatectomy and positive 68Ga-PSMA PET/CT scan
39. Validating the comprehensive complication index for assessing cumulative morbidity after robot-assisted radical cystectomy: results from a high-volume institution
40. Robot-assisted simple prostatectomy versus holmium laser enucleation for the treatment of benign prostatic hyperplasia in large (>100 ml) prostates: Updated comparative analysis from a high-volume center
41. Robot-assisted radical prostatectomy in large (≥100 gr) prostate glands: Results and different techniques for bladder neck dissection
42. En-bloc extended pelvic lymph node dissection during robot-assisted radical prostatectomy: A step-by-step description of the Aalst technique
43. Surgical outcomes of robot-assisted radical prostatectomy with the novel HUGO™ robotic system: Initial 100 cases performed at a tertiary referral robotic center
44. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder
45. Minimally invasive adrenalectomy for the treatment of malignant adrenal metastasis: Results from two high volume centers
46. Certificate of excellence completion rate of the CC-ERUS Fellowship and reasons for non-completion
47. Step-by-step description of robot-assisted radical prostatectomy with the novel HUGO RAS robotic system using the Aalst-Technique
48. The surgical learning curve for cancer control after robot-assisted radical prostatectomy
49. Robot-assisted radical prostatectomy with HUGO RAS robotic platform: First case series from an European high-volume robotic center
50. The Aalst technique for en-bloc extended pelvic lymph node dissection during robot-assisted radical prostatectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.